Accent Capital Management’s Kodiak Sciences KOD Stock Holding History

Accent Capital Management’s Portfolio KOD Stock Details KOD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.84K	Sell	227 -3	-1%	-$117	﹤0.01%	230
2026 Q1	$8.77K	Buy	+230	New	+$5.94K	﹤0.01%	213

Other funds holding KOD

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Jupiter Topco New York $245B AUM

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Accent Capital Management's KOD Position: Q2 2026 in Review

Accent Capital Management reduced its Kodiak Sciences (KOD) stake by 1.3% in Q2 2026, selling an estimated $117 and leaving 227 shares worth $8.84K. The position accounts for ﹤0.01% of the portfolio, ranked #230.

Accent Capital Management first reported a position in KOD in Q1 2026 and has held it in 2 quarters since. 201 funds tracked by Wall St. Rank hold KOD as of Q2 2026.

Accent Capital Management held 227 shares of Kodiak Sciences worth $8.84K as of Q2 2026.
Accent Capital Management sold 3 Kodiak Sciences shares in Q2 2026, an estimated $117.
Kodiak Sciences made up ﹤0.01% of Accent Capital Management's portfolio in Q2 2026, its #230 holding.
Accent Capital Management first reported a position in Kodiak Sciences in Q1 2026 and has held it in 2 quarters since.
201 funds tracked by Wall St. Rank held Kodiak Sciences as of Q2 2026.

Based on Accent Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.